Tokyo Tape
Sign in
← Medipal Holdings

Quarterly report · Q1

7459.TEDINET S100OYEC
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥838.3bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥3.29T2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥824.9bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥13.5bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥13.3bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥17.6bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥62.0bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥17.4bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥17.2bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥17.5bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥8.3bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥29.4bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.4bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥10.8bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥12.2bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥1.72Tat 2022-06-30Cons.Assets
Total assets¥1.71Tat 2022-03-31Cons.Assets
Total assets¥1.70Tat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥1.06Tat 2022-06-30Cons.Liabilities
Total liabilities¥1.06Tat 2022-03-31Cons.Liabilities
Net assets / equity¥659.0bnat 2022-06-30Cons.Net assets
Net assets / equity¥649.1bnat 2022-03-31Cons.Net assets
Net assets / equity¥645.5bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥218.8bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥243.2bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥39.392022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥140.142021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥44.992021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥36.942022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥131.412021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥42.222021-04-01 → 2021-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio31.4%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio31.0%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio31.1%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥913m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥913m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30¥98m
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥18.5bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥18.5bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥1m
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥692m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥276.2bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥276.2bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥94m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥6.5bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥544.4bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥543.6bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥817m
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥6.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥839.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥838.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥913m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥13.4bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥937m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥937m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30¥169m
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥18.1bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥18.1bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥0
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥734m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥269.7bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥269.6bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥90m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥7.0bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥538.0bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥537.1bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥846m
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥5.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥825.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥824.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥937m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥13.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 379
ItemContextValueUnit
Gain on reversal of provision for loss on disaster eiCurrentYTDDuration－JPY
Other eiPrior1YTDDuration－JPY
Other eiCurrentYTDDuration8000000JPY
Extraordinary incomePrior1YTDDuration115000000JPY
Extraordinary incomeCurrentYTDDuration3450000000JPY
Loss on sales and retirement of noncurrent assets elPrior1YTDDuration2000000JPY
Loss on sales and retirement of noncurrent assets elCurrentYTDDuration2000000JPY
Impairment loss elPrior1YTDDuration10000000JPY
Impairment loss elCurrentYTDDuration0JPY
Loss on valuation of investment securities elPrior1YTDDuration5000000JPY
Loss on valuation of investment securities elCurrentYTDDuration3785000000JPY
Other elPrior1YTDDuration2000000JPY
Other elCurrentYTDDuration20000000JPY
Extraordinary lossPrior1YTDDuration20000000JPY
Extraordinary lossCurrentYTDDuration3809000000JPY
Income before income taxesPrior1YTDDuration17458000000JPY
Income before income taxesCurrentYTDDuration17227000000JPY
Income taxes currentPrior1YTDDuration9916000000JPY
Income taxes currentCurrentYTDDuration11096000000JPY
Income taxes deferredPrior1YTDDuration-4616000000JPY
Income taxes deferredCurrentYTDDuration-4633000000JPY
Income taxesPrior1YTDDuration5300000000JPY
Income taxesCurrentYTDDuration6462000000JPY
Profit lossPrior1YTDDuration12157000000JPY
Profit lossCurrentYTDDuration10764000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration2712000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration2494000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration9445000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration8270000000JPY
Profit lossPrior1YTDDuration12157000000JPY
Profit lossCurrentYTDDuration10764000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration93000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration4661000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration-2000000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration0JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-67000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-124000000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration424000000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration666000000JPY
Other comprehensive incomePrior1YTDDuration448000000JPY
Other comprehensive incomeCurrentYTDDuration5203000000JPY
Comprehensive incomePrior1YTDDuration12606000000JPY
Comprehensive incomeCurrentYTDDuration15968000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration10351000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration13440000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration2254000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration2528000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember537142000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E02632-000CosmeticsDailyNecessitiesAndOTCPharmaceuticalWholesaleBusinessReportableSegmentsMember269599000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleBusinessReportableSegmentsMember18135000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass